AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19 Read more
COVID-19 vaccines supply may meet, even exceed demand in India by third quarter: AstraZeneca India Head Read more
We need companies to apply access approaches more systematically, consistently and at a larger scale Read more
A strong and independent voice of the nutraceutical industry in the country is still lacking Read more
Zydus’ Desidustat efficacious in treating hypoxia in Mexico’s hospitalised COVID-19 patients: Study Read more